DICOT — Dicot Pharma AB Balance Sheet
0.000.00%
- SEK2.00bn
- SEK1.90bn
- SEK0.03m
Annual balance sheet for Dicot Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 20.3 | 30.3 | 9.38 | 47.3 | 113 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0 | 0.001 | — | — | 4.82 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 21.6 | 31.7 | 12.4 | 53.5 | 124 |
| Net Property, Plant And Equipment | 0.036 | 0.028 | 0.021 | 0.013 | 0 |
| Other Long Term Assets | |||||
| Total Assets | 21.6 | 31.8 | 12.4 | 53.6 | 124 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.95 | 3.42 | 7.01 | 9.16 | 12 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.95 | 3.42 | 7.01 | 9.16 | 12 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 19.7 | 28.4 | 5.36 | 44.4 | 112 |
| Total Liabilities & Shareholders' Equity | 21.6 | 31.8 | 12.4 | 53.6 | 124 |
| Total Common Shares Outstanding |